Earnings History Data for PDS Biotechnology Corporation (PDSB) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

PDS Biotechnology Corporation

PDS Biotechnology Corp. is an immuno-oncology company. It is focused on developing a pipeline of clinical-stage immunotherapies to treat cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, cancer and other cancers. The company's products are based on the proprietary Versamune(R) platform technology, which activates and directs the human immune system. PDS Biotechnology Corp, formerly known as Edge Therapeutics Inc., is based in Berkeley Heights, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-03-2024	PM		PDSB	PDS Biotechnology Corporation	147.14	-0.34	-0.39	-0.67	PDS Biotechnology GAAP EPS of -$1.39 beats by $0.06 [3/27/2024 7:31 AM]	3.86	-0.62 (-13.84%)	4.00	-0.48 (-10.71%)	3.61 - 10.27	3,994,959	830,000	287,896
PDS Biotechnology FY 2023 Earnings Preview [3/26/2024 1:47 PM] PDS Biotechnology GAAP EPS of -$1.39 beats by $0.06 [3/27/2024 7:31 AM]
14-11-2023	PM		PDSB	PDS Biotechnology Corporation	164.84	-0.35	-0.42	-0.26	PDS Biotechnology GAAP EPS of -$0.35 beats by $0.10 [11/14/2023 7:37 AM]	6.22	0.97 (18.46%)	5.49	0.24 (4.47%)	3.80 - 13.65	1,196,231	520,000	20,555
PDS Biotechnology Q3 2023 Earnings Preview [11/13/2023 1:31 PM] PDS Biotechnology Q3 2023 Earnings Preview [11/13/2023 1:09 PM] PDS Biotechnology GAAP EPS of -$0.35 beats by $0.10 [11/14/2023 7:37 AM]
14-08-2023	PM		PDSB	PDS Biotechnology Corporation	147.80	-0.37	-0.37	-0.20	PDS Biotechnology GAAP EPS of -$0.37 misses by $0.02 [8/14/2023 7:37 AM]	5.33	0.48 (9.90%)	5.15	0.30 (6.19%)	2.89 - 13.65	749,077	440,000	10,698
PDS Biotechnology GAAP EPS of -$0.37 misses by $0.02 [8/14/2023 7:37 AM] PDS Biotech gains after updates on pivotal trial for lead asset [8/14/2023 9:26 AM]
15-05-2023	PM	7:30 AM ET (May 15)	PDSB	PDS Biotechnology Corporation	206.00	-0.32	-0.31	-0.32	PDS Biotechnology GAAP EPS of -$0.32 misses by $0.01 [5/15/2023 7:36 AM]	6.93	0.48 (7.44%)	0.0	0.0 (0.00%)	2.89 - 13.65	311,030	190,000	0
PDS Biotechnology GAAP EPS of -$0.32 misses by $0.01 [5/15/2023 7:36 AM]
28-03-2023	PM	7:30 AM ET (Mar 28)	PDSB	PDS Biotechnology Corporation	229.08	-0.67	-0.30	-0.23	PDS Biotechnology GAAP EPS of -$1.43 misses by $0.35 [3/28/2023 7:34 AM]	5.85	0.17 (2.99%)	0.0	0.0 (0.00%)	2.89 - 13.65	400,016	350,000	0
PDS Biotechnology Q4 2022 Earnings Preview [3/27/2023 1:52 PM] PDS Biotechnology GAAP EPS of -$1.43 misses by $0.35 [3/28/2023 7:34 AM]
14-11-2022	PM	7:00 AM ET (Nov 14)	PDSB	PDS Biotechnology Corporation	157.38	-0.26	-0.26	-0.24	PDS Biotechnology GAAP EPS of -$0.26 beats by $0.02 [11/14/2022 7:36 AM]	7.03	1.43 (25.54%)	6.83	1.23 (21.96%)	2.89 - 11.57	14,452,786	270,000	2,990,403
PDS Biotechnology GAAP EPS of -$0.26 beats by $0.02 [11/14/2022 7:36 AM] PDS Biotech surges 22% as drug shows response in cervical cancer patients in phase 2 trial [11/14/2022 8:56 AM] PDS Biotech Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-14-22 07:30AM] PDS Biotech Announces 100% Clinical Response in Cervical Cancer Patients in Preliminary Data from IMMUNOCERV Phase 2 Clinical Trial [Nov-14-22 07:00AM]
08-08-2022	PM	7:00 AM ET (Aug 8)	PDSB	PDS Biotechnology Corporation	114.66	-0.20	-0.30	-0.22	PDS Biotechnology GAAP EPS of -$0.20 beats by $0.08 [8/8/2022 7:13 AM]	5.20	-0.11 (-2.07%)	5.33	0.02 (0.38%)	2.91 - 17.85	391,226	270,000	7,694
PDS Biotechnology GAAP EPS of -$0.20 beats by $0.08 [8/8/2022 7:13 AM] PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-08-22 07:00AM]
11-05-2022	PM	7:00 AM ET (May 11)	PDSB	PDS Biotechnology Corporation	131.44	-0.32	-0.23	-0.14	PDS Biotechnology GAAP EPS of -$0.32 misses by $0.09 [5/11/2022 7:08 AM]	3.76	-0.71 (-15.97%)	4.35	-0.12 (-2.68%)	3.65 - 17.85	773,462	280,000	5,428
PDS Biotechnology GAAP EPS of -$0.32 misses by $0.09 [5/11/2022 7:08 AM] PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial Results [May-11-22 07:00AM]
31-03-2022	PM	7:00 AM ET (Mar 31)	PDSB	PDS Biotechnology Corporation	172.05	-0.23	-0.23	-0.16	PDS Biotechnology GAAP EPS of -$0.66 beats by $0.05 [3/31/2022 7:06 AM]	6.17	-0.12 (-1.91%)	6.29	0.0 (0.00%)	4.10 - 17.85	327,481	210,000	427
PDS Biotechnology Q4 2021 Earnings Preview [3/30/2022 1:21 PM] PDS Biotechnology GAAP EPS of -$0.66 beats by $0.05 [3/31/2022 7:06 AM] PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2021 Financial Results [Mar-31-22 07:00AM]
10-11-2021	PM	7:05 AM ET (Nov 10)	PDSB	PDS Biotechnology Corporation	326.59	-0.24	-0.22	-0.23	PDS Biotechnology EPS misses by $0.04 [11/10/2021 7:17 AM]	10.21	-0.46 (-4.31%)	10.53	-0.14 (-1.31%)	1.92 - 17.85	764,655	350,000	7,606
PDS Biotechnology Q3 2021 Earnings Preview [11/9/2021 11:52 AM] PDS Biotechnology EPS misses by $0.04 [11/10/2021 7:17 AM] PDS Biotech Provides Business Update and Reports Third Quarter 2021 Financial Results [Nov-10-21 07:00AM]
12-08-2021	PM	7:00 AM ET (Aug 12)	PDSB	PDS Biotechnology Corporation	308.06	-0.22	-0.20	-0.19	PDS Biotechnology EPS beats by $0.13 [8/12/2021 7:18 AM]	10.89	0.30 (2.83%)	10.66	0.07 (0.66%)	1.84 - 13.48	503,338	350,000	7,396
PDS Biotechnology EPS beats by $0.13 [8/12/2021 7:18 AM] PDS Biotech Provides Business Update and Reports Second Quarter 2021 Financial Results [Aug-12-21 07:05AM]
13-05-2021	PM	7:00 AM ET (May 13)	PDSB	PDS Biotechnology Corporation	103.82	-0.14	-0.20	-0.39	PDS Biotechnology EPS beats by $0.05 [5/13/2021 7:07 AM]	4.48	0.08 (1.82%)	4.72	0.32 (7.27%)	0.82 - 7.30	429,743	600,000	6,864
PDS Biotechnology EPS beats by $0.05 [5/13/2021 7:07 AM] PDS Biotechnology Announces Participation in Noble Capital Markets C-Suite Interview Series [May-12-21 08:00AM] PDS Biotechnology Corp. to Host Earnings Call [May-13-21 05:45AM] PDS Biotech Provides Business Update and Reports First Quarter 2021 Financial Results [May-13-21 07:00AM]
18-03-2021	PM	6:00 AM ET (Mar 18)	PDSB	PDS Biotechnology Corporation	121.55	-0.16	-0.18	-0.52	PDS Biotechnology EPS misses by $0.06 [3/18/2021 7:07 AM]	4.91	-0.36 (-6.83%)	5.40	0.13 (2.47%)	0.62 - 7.30	862,495	5,330,000	28,056
PDS Biotechnology EPS misses by $0.06 [3/18/2021 7:07 AM] PDS Biotech Announces Presentation and Panel Participation at the Benzinga Biotech Small Cap Conference [Mar-17-21 08:30AM] PDS Biotechnology Corp. to Host Earnings Call [Mar-18-21 06:15AM] PDS Biotech Reports Financial Results for the Year Ended December 31, 2020 and Provides Business Update [Mar-18-21 07:00AM]
11-11-2020	AH		PDSB	PDS Biotechnology Corporation	45.41	-0.23	-0.27	-1.10	PDS Biotechnology reports Q3 results [11/11/2020 4:07 PM]	2.08	-0.14 (-6.50%)	2.18	-0.05 (-2.24%)	0.62 - 4.98	256,273	631,417	1,754

13-08-2020	PM	6:00 AM ET (Aug 13)	PDSB	PDS Biotechnology Corporation	46.08	-0.19	-0.26	-0.75		2.88	-0.06 (-2.04%)	2.98	0.04 (1.36%)	0.62 - 6.50	736,996	1,694,598	50,023

13-05-2020	PM	6:00 AM ET (May 13)	PDSB	PDS Biotechnology Corporation	14.49	-0.39	-0.15	-1.07		0.8732	-0.04 (-3.87%)	0.92	0.05 (5.36%)	0.62 - 9.45	219,328	283,076	2,000